首页 | 本学科首页   官方微博 | 高级检索  
检索        

子宫内膜异位患者TGF-β、VEGF和ICAM-1水平及与临床分期关系
引用本文:丁屹,袁霞,顾文文,陈继明.子宫内膜异位患者TGF-β、VEGF和ICAM-1水平及与临床分期关系[J].中国计划生育学杂志,2020(4):543-545.
作者姓名:丁屹  袁霞  顾文文  陈继明
作者单位:江苏省常州市金坛区人民医院;江苏省常州市第二人民医院
基金项目:江苏省常州市科技局科技支撑计划(CE20175004)。
摘    要:目的:观察子宫内膜异位症(EMS)患者纤维化因子转化生长因子-β(TGF-β)、血管内皮生长因子(VEGF)和细胞间黏附分子-1(ICAM-1)水平,并分析其临床意义。方法:选取2017年2月-2018年8月本院接受治疗的子EMS患者100例为观察组,同期体检健康女性100例为对照组。比较两组及观察组不同临床分期患者TGF-β、VEGF和ICAM-1水平,Pearson相关分析法分析观察组TGF-β水平与VEGF、ICAM-1水平的相关性。结果:观察组TGF-β(389.25±12.36pg/ml)、VEGF(178.45±10.02pg/ml)和ICAM-1(186.34±13.15μg/ml)高于对照组(322.16±15.04pg/ml、120.27±8.45pg/ml、104.28±12.93μg/ml(均P<0.001);观察组临床分期Ⅲ-Ⅳ期患者TGF-β、VEGF和ICAM-1水平(411.35±12.95pg/ml、192.92±8.35pg/ml、204.15±15.17μg/ml)高于Ⅰ-Ⅱ期患者(352.94±15.24pg/ml、155.36±7.28pg/ml、168.28±10.02μg/ml)(均P<0.001);TGF-β水平与VEGF、ICAM-1水平正相关(r=0.523、0.489,P<0.05)。结论:子宫内膜异位症患者的TGF-β、VEGF和ICAM-1水平较正常者高,且临床分期高者水平更高。TGF-β与VEGF、ICAM-1水平正相关。

关 键 词:子宫内膜异位症  纤维化因子转化生长因子  血管内皮生长因子  细胞间黏附分子-1

The relationship between the levels of TGF-β,VEGF and ICAM-1 of women with endometriosis and their clinical staging of endometriosis
DING Yi,YUAN Xia,GU Wenwen,CHEN Jiming.The relationship between the levels of TGF-β,VEGF and ICAM-1 of women with endometriosis and their clinical staging of endometriosis[J].Chinese Journal of Family Planning,2020(4):543-545.
Authors:DING Yi  YUAN Xia  GU Wenwen  CHEN Jiming
Institution:(Jintan District People's Hospital, Changzhou, Jiangsu Province, 213200;2 The Second People's Hospital of Changzhou)
Abstract:Objective:To observe the levels of fibroblast growth factor-β(TGF-β),VEGF and ICAM-1 of women with endometriosis,and to analyze their clinical significance.Methods:100 women with endometriosis were enrolled in study group,and 100 healthy women were selected in control group from February to February 2018.The levels of TGF-β,VEGF and ICAM-1 of women were compared between the two groups,and the levels of TGF-β,VEGF and ICAM-1 of women with different clinical staging of endometriosis were observed.Pearson correlation analysis was used to analyze the correlation between TGF-βlevel and the levels of VEGF and ICAM-1 of women in the study group.Results:The levels of TGF-β,VEGF and ICAM-1 of women in the study group were 389.25±12.36pg/ml,178.45±10.02pg/ml,and 186.34±13.15μg/ml,respectively,which were significant higher than those(322.16±15.04pg/ml,120.27±8.45pg/ml,104.28±12.93μg/ml,respectively)of women in the control group.In the study group,the levels of TGF-β,VEGF and ICAM-1 of women with endometriosis clinical stage III-IV were 411.35±12.95pg/ml,192.92±8.35pg/ml,204.15±15.17μg/ml,respectively,which were significant higher than those(352.94±15.24pg/ml,155.36±7.28pg/ml,and 168.28±10.02μg/ml,respectively)of women with endometriosis clinical stage I-II(all P<0.001).TGF-βlevel of women in the study group was positively correlated with their VEGF and ICAM-1 levels(r=0.523,0.489,P<0.05).Conclusion:The levels of TGF-β,VEGF and ICAM-1 of women with endometriosis have increased,and which’s TGF-βlevel is positively correlated with their VEGF and ICAM-1 levels.
Keywords:Endometriosis  Fibrogenic transforming growth factor  VEGF  ICAM-1
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号